clarithromycine sandoz 500 mg filmomh. tabl.
sandoz sa-nv - clarithromycine 500 mg - filmomhulde tablet - 500 mg - clarithromycine 500 mg - clarithromycin
clarithromycine teva 500 mg filmomh. tabl.
teva pharma belgium sa-nv - clarithromycine 500 mg - filmomhulde tablet - 500 mg - clarithromycine 500 mg - clarithromycin
clarithromycine teva 250 mg filmomh. tabl.
teva pharma belgium sa-nv - clarithromycine 250 mg - filmomhulde tablet - 250 mg - clarithromycine 250 mg - clarithromycin
heliclar 500 mg filmomh. tabl.
viatris healthcare sa-nv - clarithromycine 500 mg - filmomhulde tablet - 500 mg - clarithromycine 500 mg - clarithromycin
itraconazol sandoz 100 mg harde caps.
sandoz sa-nv - itraconazol 100 mg - capsule, hard - 100 mg - itraconazol 100 mg - itraconazole
maclar 500 mg filmomh. tabl.
viatris healthcare sa-nv - clarithromycine 500 mg - filmomhulde tablet - 500 mg - clarithromycine 500 mg - clarithromycin
mysoline 250 mg tabl.
laboratoires serb - primidon 250 mg - tablet - 250 mg - primidon 250 mg - primidone
xenleta
nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - antibacteriële middelen voor systemisch gebruik, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. aandacht moet worden gegeven aan de officiële richtlijnen betreffende het juiste gebruik van antibacteriële agentia.
tukysa
seagen b.v. - tucatinib - breast neoplasms; neoplasm metastasis - antineoplastische middelen - tukysa is indicated in combination with trastuzumab and capecitabine for the treatment of adult patients with her2‑positive locally advanced or metastatic breast cancer who have received at least 2 prior anti‑her2 treatment regimens.
clarithromycine viatris 250 mg filmomh. tabl.
viatris gx bv-srl - clarithromycine 250 mg - filmomhulde tablet - clarithromycin